Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 469358, 14 pages
http://dx.doi.org/10.1155/2014/469358
Research Article

Proteomic Analysis of Lung Tissue in a Rat Acute Lung Injury Model: Identification of PRDX1 as a Promoter of Inflammation

1State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang West Road, Guangzhou, Guangdong 510120, China
2Intensive Care Unit, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
3Infection Control Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

Received 20 February 2014; Revised 1 May 2014; Accepted 19 May 2014; Published 15 June 2014

Academic Editor: Elzbieta Kolaczkowska

Copyright © 2014 Dongdong Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. D. Rubenfeld, E. Caldwell, E. Peabody et al., “Incidence and outcomes of acute lung injury,” The New England Journal of Medicine, vol. 353, no. 16, pp. 1685–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Matthay, L. B. Ware, and G. A. Zimmerman, “The acute respiratory distress syndrome,” Journal of Clinical Investigation, vol. 122, no. 8, pp. 2731–2740, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Liaudet, J. G. Mabley, P. Pacher et al., “Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury,” Annals of Surgery, vol. 235, no. 4, pp. 568–578, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Gao and K. C. Barnes, “Recent advances in genetic predisposition to clinical acute lung injury,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 296, no. 5, pp. L713–L725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Curley, M. Hayes, and J. G. Laffey, “Can “permissive” hypercapnia modulate the severity of sepsis-induced ALI/ARDS?” Critical Care, vol. 15, no. 2, article 212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Opitz, V. van Laak, J. Eitel, and N. Suttorp, “Innate immune recognition in infectious and noninfectious diseases of the lung,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 12, pp. 1294–1309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Imai, K. Kuba, S. Rao et al., “Angiotensin-converting enzyme 2 protects from severe acute lung failure,” Nature, vol. 436, no. 7047, pp. 112–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Kuba, Y. Imai, and J. M. Penninger, “Angiotensin-converting enzyme 2 in lung diseases,” Current Opinion in Pharmacology, vol. 6, no. 3, pp. 271–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. N. Serhan, S. D. Brain, C. D. Buckley et al., “Resolution of inflammation: state of the art, definitions and terms,” FASEB Journal, vol. 21, no. 2, pp. 325–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. G. Righetti, A. Castagna, and M. Hamdan, “Recent trends in proteome analysis,” Advances in Chromatography, vol. 42, pp. 269–321, 2003. View at Google Scholar · View at Scopus
  11. K.-X. Liu, C. Li, Y.-S. Li et al., “Proteomic analysis of intestinal ischemia/reperfusion injury and ischemic preconditioning in rats reveals the protective role of aldose reductase,” Proteomics, vol. 10, no. 24, pp. 4463–4475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. Janz and L. B. Ware, “Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials,” Seminars in Respiratory and Critical Care Medicine, vol. 34, no. 4, pp. 537–548, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ménoret, S. Kumar, and A. T. Vella, “Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury,” PLoS ONE, vol. 7, no. 7, Article ID e40184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. M. Schnapp, S. Donohoe, J. Chen et al., “Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury,” American Journal of Pathology, vol. 169, no. 1, pp. 86–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. D. W. Chang, S. Hayashi, S. A. Gharib et al., “Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 7, pp. 701–709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. E. Cabrera-Benitez, E. Pérez-Roth, M. Casula et al., “Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury model,” PLoS ONE, vol. 7, no. 11, Article ID e48468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. W. Cripps, M. L. Dunkley, and R. L. Clancy, “Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats,” Infection and Immunity, vol. 62, no. 4, pp. 1427–1436, 1994. View at Google Scholar · View at Scopus
  18. J. Vanderzwan, L. McCaig, S. Mehta et al., “Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia,” The European Respiratory Journal, vol. 12, no. 6, pp. 1388–1396, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Nishina, K. Mikawa, Y. Takao, N. Maekawa, M. Shiga, and H. Obara, “ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits,” Anesthesia and Analgesia, vol. 84, no. 5, pp. 1097–1103, 1997. View at Google Scholar · View at Scopus
  20. T. Eckle, L. Füllbier, M. Wehrmann et al., “Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury,” Journal of Immunology, vol. 178, no. 12, pp. 8127–8137, 2007. View at Google Scholar · View at Scopus
  21. J. Li, N. Zhang, L.-B. Song et al., “Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival,” Clinical Cancer Research, vol. 14, no. 11, pp. 3319–3326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E.-J. Park, J. Yi, K.-H. Chung, D.-Y. Ryu, J. Choi, and K. Park, “Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells,” Toxicology Letters, vol. 180, no. 3, pp. 222–229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Riddell, W. Bshara, M. T. Moser, J. A. Spernyak, B. A. Foster, and S. O. Gollnick, “Peroxiredoxin 1 controls prostate cancer growth through toll-like receptor 4-dependent regulation of tumor vasculature,” Cancer Research, vol. 71, no. 5, pp. 1637–1646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. W. Chang, S. H. Lee, Y. Lu, and Y. J. Yoo, “Transforming growth factor-β1 induces the non-classical secretion of peroxiredoxin-I in A549 cells,” Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 118–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Liu, P. Mao, X. Q. Liu, W. Q. He, H. Y. Mo, and Y. M. Li, “Lipopolysaccharide induced expression of peroxiredoxin 1 in airway epithelial cell,” Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, vol. 25, no. 3, pp. 136–139, 2013. View at Google Scholar
  26. J. R. Riddell, X.-Y. Wang, H. Minderman, and S. O. Gollnick, “Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4,” Journal of Immunology, vol. 184, no. 2, pp. 1022–1030, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Bellani, C. Messa, L. Guerra et al., “Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET/CT study,” Critical Care Medicine, vol. 37, no. 7, pp. 2216–2222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Bellani, L. Guerra, G. Musch et al., “Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 9, pp. 1193–1199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Sun, J. W. Breslin, J. Zhu, S. Y. Yuan, and M. H. Wu, “Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability,” Microcirculation, vol. 13, no. 3, pp. 237–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. G. Mckenzie and A. J. Ridley, “Roles of Rho/ROCK and MLCK in TNF-α-induced changes in endothelial morphology and permeability,” Journal of Cellular Physiology, vol. 213, no. 1, pp. 221–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Jia, M. Xu, W. Zhen et al., “Novel anti-oxidative role of calreticulin in protecting A549 human type II alveolar epithelial cells against hypoxic injury,” American Journal of Physiology: Cell Physiology, vol. 294, no. 1, pp. C47–C55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Li and R. M. Jackson, “Reactive species mechanisms of cellular hypoxia-reoxygenation injury,” American Journal of Physiology: Cell Physiology, vol. 282, no. 2, pp. C227–C241, 2002. View at Google Scholar · View at Scopus
  33. H. Liu, E. Peatman, W. Wang et al., “Molecular responses of calreticulin genes to iron overload and bacterial challenge in channel catfish (Ictalurus punctatus),” Developmental and Comparative Immunology, vol. 35, no. 3, pp. 267–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. J. Ghio, J. D. Carter, J. H. Richards, L. D. Richer, C. K. Grissom, and M. R. Elstad, “Iron and iron-related proteins in the lower respiratory tract of patients with acute respiratory distress syndrome,” Critical Care Medicine, vol. 31, no. 2, pp. 395–400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M.-F. Chen, P. C. Keng, H. Shau et al., “Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 2, pp. 581–591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. R. Riddell, P. Maier, S. N. Sass, M. T. Moser, B. A. Foster, and S. O. Gollnick, “Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α,” PLoS ONE, vol. 7, no. 11, Article ID e50394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Shichita, E. Hasegawa, A. Kimura et al., “Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain,” Nature Medicine, vol. 18, no. 6, pp. 911–917, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Gharib, E. Nguyen, W. A. Altemeier et al., “Of mice and men: comparative proteomics of bronchoalveolar fluid,” The European Respiratory Journal, vol. 35, no. 6, pp. 1388–1395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S.-U. Kim, Y.-H. Park, J.-S. Min et al., “Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation,” Journal of Neuroimmunology, vol. 259, no. 1-2, pp. 26–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. W. Kang, H. Z. Chae, M. S. Seo, K. Kim, I. C. Baines, and S. G. Rhee, “Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generatedin response to growth factors and tumor necrosis factor-α,” The Journal of Biological Chemistry, vol. 273, no. 11, pp. 6297–6302, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Ishii, E. Warabi, and T. Yanagawa, “Novel roles of peroxiredoxins in inflammation, cancer and innate immunity,” Journal of Clinical Biochemistry and Nutrition, vol. 50, no. 2, pp. 91–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. W. Kang, S. G. Rhee, T.-S. Chang, W. Jeong, and M. H. Choi, “2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications,” Trends in Molecular Medicine, vol. 11, no. 12, pp. 571–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. G. R. Sue, Z. C. Ho, and K. Kim, “Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling,” Free Radical Biology and Medicine, vol. 38, no. 12, pp. 1543–1552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. A. Wood, E. Schröder, J. R. Harris, and L. B. Poole, “Structure, mechanism and regulation of peroxiredoxins,” Trends in Biochemical Sciences, vol. 28, no. 1, pp. 32–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Yanagisawa, E. Warabi, K.-I. Inoue et al., “Peroxiredoxin I null mice exhibits reduced acute lung inflammation following ozone exposure,” Journal of Biochemistry, vol. 152, no. 6, pp. 595–601, 2012. View at Publisher · View at Google Scholar · View at Scopus